Event Description:  Agenda
8:00 Introductions and Housekeeping – Perry Shen, MD

Colorectal Liver Metastases

8:10 Hepatic Arterial Infusion Chemotherapy for CLM: Are we missing the boat? Caio Rocha Lima, MD

8:30 Disappearing Liver Metastases: Is there a role for surgical resection? Perry Shen, MD
8:50 Update on Chemotherapy Associated Hepatic Toxicity in CRC - Sean Rudnick, MD

9:10 Panel Discussion - Moderator: Clancy Clark, MD

9:30 Break

Hepatocellular Carcinoma

9:45 Rapidly Evolving Systemic Treatment Options for HCC and How to Better Sequence Them – Ravi Paluri, MD

10:05 Update on Ablative Therapy for HCC: Moving beyond the patients that are not a candidate for transplant or surgical resection Erin Baker, MD

10:25 Ex-Vivo Hepatectomy for Primary and Secondary Malignancies of the Liver - David Levi, MD

10:45 Panel Discussion – Moderator: Michael McCormack, MD

Pancreatic Adenocarcinoma

11:10 Perioperative Therapy for Resectable Pancreatic Cancer: Is the neoadjuvant approach ready for prime time? Michael McCormack, MD

11:30 Preoperative Assessment of Patients for Pancreatic Surgery - Clancy Clark, MD

11:50 Role of EUS in the Management of Pancreatic Cystic Lesions - Darius Jahann, MD

12:10 Panel Discussion – Moderator: Perry Shen, MD

12:30 Lunch

Intrahepatic Cholangiocarcinoma

1:30 Systemic Therapy for Advanced ICCA: Beyond Gemcitabine and platinum - Keynote: Rachna Shroff, MD

2:00 Role of PET imaging for Biliary Malignancies - Jean Claude Urbain, MD

2:20 Neoadjuvant and Adjuvant Therapy for Resectable Biliary Cancers: BILCAP is not enough – Mohamed Salem, MD

2:40 Panel Discussion – Moderator: Caio Rocha Lima, MD

3:00 Adjourn